The Maine-based company is the seventh to receive such a license “for the bulk manufacture of cannabis to supply marijuana, cannabis extracts and THC to researchers.”
A new preprint study from food chemists and public health experts at the Chemical and Veterinary Investigation Office Karlsruhe, Germany, provides a deeper look into the European Food Safety Authority's decision to halt novel food applications for CBD products.
The panel will help the lab test hemp samples for 18 cannabinoids, 105 pesticides, 24 heavy metals, 55 potential residual solvents, 17 different microorganisms, and every required mycotoxin to detect parts per billion.
The multi-state operator has pulled tens of thousands of its products off of New York State shelves after the company switched to an unauthorized way of labeling product potency.
A new study by researchers at Dana-Farber Cancer Institute suggests that despite a commitment by many dispensary workers to educate themselves about medical cannabis, dispensaries often prioritize sales skills over cannabis knowledge.
This is the first known human health risk assessment to evaluate the large number of heavy metals that may be present in cannabis flower, concentrates and vape devices.
The company now offers seamless testing services for cannabis across California, Michigan, Oregon, and Colorado, as well as hemp testing capabilities nationwide.
By studying human brain organoids — tissue cultures grown from stem cells that can mimic the developing brain — researchers have found that LSD regulates numerous processes related to neuroplasticity in the human brain.
By demonstrating that ketamine induces only a brief increase in dopamine and does not alter neuronal communication, a team from the University of Geneva suggests that its therapeutic use may be safe.